688189 南新制药
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产154,894-5.30%163,557184,895200,731223,585
在建工程2,463597.73%3535732401,275
无形资产134,974-5.70%143,135124,284138,006158,413
商誉0--010,84510,84513,569
其他非流动资产174,86827.60%137,043126,928108,614120,846
467,1995.20%444,089447,525458,436517,689

流动资产
货币资金439,385-10.38%490,270665,761713,472730,668
应收账款77,812-60.22%195,598520,669728,193590,813
存货55,637-9.04%61,16730,36627,01561,425
其他流动资产29,592-5.50%31,31555,06327,492230,275
602,425-22.60%778,3501,271,8581,496,1721,613,181

流动负债
短期借款148,167-32.09%218,187322,950488,733385,437
应付票据0--00080,000
应付帐款15,756-60.20%39,59139,54837,49676,467
其他流动负债69,394-15.45%82,07565,538122,127132,766
233,317-31.35%339,853428,035648,355674,671
流动资产净值369,108-15.82%438,497843,822847,817938,510
资产总额减流动负债836,308-5.24%882,5861,291,3481,306,2531,456,199

非流动负债
长期借款0--00050,846
应付债券0--0000
其他非流动负债3,797-11.29%4,2805,7689,88111,370
3,797-11.29%4,2805,7689,88162,216

总权益
    实收股本274,4000.00%274,400274,400196,000140,000
    储备项目620,222-6.34%662,1921,029,0961,118,3651,253,197
股东权益894,622-4.48%936,5921,303,4961,314,3651,393,197
非控股权益(62,110)6.56%(58,286)(17,916)(17,993)786